LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...

AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international ...

One possible explanation for the gap is the availability of highly efficacious CAR-T therapies in the U.S. and Europe serving as later-line therapies to improve survival outcomes. The FDA has also ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive ...

Roche (RHHBY) warns Trump's executive order for drug price cuts could jeopardize its recently announced significant ...

The National Health Insurance Authority has signed an expanded Memorandum of Understanding with a leading multinational ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...